Figure 3.
![Figure 3. Prognostic impact of β2 microglobulin level and chromosome 13 abnormalities (detected by fluorescence in situ hybridization [FISH] analysis) in 110 patients treated with high-dose therapy: progression-free survival. / Abbreviations: O/N, number of deaths without progression and progressions/number of patients; SE, standard error](https://ash.silverchair-cdn.com/ash/content_public/journal/hematology/2002/1/10.1182_asheducation-2002.1.214/3/anderson_fig3.jpeg?Expires=1752342208&Signature=lhvkHWQnTV9Nvgm5gBXzJfwIeOi~MNB09Zl2WI6t144AoUJ6ll5lCTlIFZljWe9zNP3bz9c-XLZFsMBXSgqvaOA5uBJPvNZH53fOuT3nomTpQ4IPWMm5xCHVW2yPY6Jj-UhmT-ek6zIVoUTNolvBrvhTID-IuGRB9feXTSqeJ4PZ1LbpF1FeuSl9oPen~ylRIcz2pHyzRlrjG8r3iKa8dIU1mfHy~tGRVkD5arOnc4M3ZhfMzyTAvA4IOqdSt6cvuh8UoPssQHCOvImvOMkwiTc6P6xU~W3gRkm6QLNm60CQfgqN9zKrIrgB2-D06XzLxkSKLK7z3z6dE6zfeom41A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Prognostic impact of β2 microglobulin level and chromosome 13 abnormalities (detected by fluorescence in situ hybridization [FISH] analysis) in 110 patients treated with high-dose therapy: progression-free survival.
Abbreviations: O/N, number of deaths without progression and progressions/number of patients; SE, standard error
